Cross-border M&A, deal structuring, due diligence, and corporate finance strategies for mid-market and enterprise transactions.
A wave of landmark transactions — from the $58 billion Devon-Coterra energy merger to Gilead’s $7.8 billion biotech acquisition — signals a structural realignment in global M&A. European dealmakers and multinational boards must act now to position for an accelerating deal environment in 2025–2026.
The 2026 M&A cycle is accelerating, led by Devon Energy and Coterra Energy’s $58 billion merger and a wave of cross-border private equity transactions reshaping energy, biopharma, and fintech. For CFOs, General Counsel, and M&A Directors, the strategic imperative is precision execution—anchored in rigorous due diligence and proactive regulatory mapping.
The $58 billion Devon-Coterra merger and a wave of cross-border private equity deals signal a decisive shift in the 2025 M&A landscape. Decision-makers must act on structural trends in energy, biopharma, and environmental services before the window narrows.
The $58 billion Devon-Coterra merger and a record $813.3 billion in 2026 M&A deal value signal a structural realignment across energy, technology, and biotech sectors. Decision-makers must adapt their due diligence, regulatory, and post-merger integration frameworks to compete in an increasingly complex cross-border deal environment.
The $250 billion SpaceX-xAI acquisition and record private equity activity are redefining M&A valuation benchmarks in 2026. CFOs and M&A Directors must recalibrate cross-border strategy as AI integration and sponsor capital reshape deal dynamics globally.